Red Tree Venture — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
BiotechSan Francisco, US
Donald Manning(Executive Officer)Scott Harris(Executive Officer)Julien Mamet(Executive Officer, Director)Rick Orr(Executive Officer, Director)
BoardDennis Podlesak(Director)Eckard Weber(Director)
Board seatHeath Lukatch· per SEC Form D · $16M raise · filed Jan 2017
Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).
BiotechHealthtechMedical DevicesSouth San Francisco, US
John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)Rob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)David Prichard(Chief Operating Officer)
Board seatHeath Lukatch· per SEC Form D · $12.3M raise · filed Feb 2018
Co-investorsOUP (Osage University Partners)Vivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.